Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes

OBJECTIVE: To investigate the pharmacokinetic and pharmacodynamic properties and safety of a novel formulation of insulin aspart (AT247) versus two currently marketed insulin aspart formulations (NovoRapid [IAsp] and Fiasp [faster IAsp]). RESEARCH DESIGN AND METHODS: This single-center, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Svehlikova, Eva, Mursic, Ines, Augustin, Thomas, Magnes, Christoph, Gerring, David, Jezek, Jan, Schwarzenbacher, Daniela, Ratzer, Maria, Wolf, Michael, Howell, Sarah, Zakrzewski, Leon, Urschitz, Martina, Tschapeller, Bernd, Gatschelhofer, Christina, Feichtner, Franz, Lawrence, Fiona, Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818330/
https://www.ncbi.nlm.nih.gov/pubmed/33328285
http://dx.doi.org/10.2337/dc20-1017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818330/
https://www.ncbi.nlm.nih.gov/pubmed/33328285
http://dx.doi.org/10.2337/dc20-1017

Ejemplares similares